News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Undetectable viral load and treatment as prevention news

Show

From To
Undetectable viral load and treatment as prevention
Reclaiming my time!

Every time I take my medicine, it is an act of preventing transmission, and survival. Never again will I see myself as ‘unclean’ or ‘a risk to others’. The only time HIV plays a role in my life is when I take my medication before bed.

Published
22 March 2019
From
PrEPing MALTA
Undetectable viral load and treatment as prevention
Healthcare providers should discuss U=U with all their HIV-positive patients

Healthcare providers should inform all patients with HIV they cannot transmit HIV to a sexual partner when their viral load is undetectable, argue the authors of  a strongly

Published
18 March 2019
By
Michael Carter
Undetectable viral load and treatment as prevention
U=U is a human rights issue

Undetectable = Untransmittable (U=U) is a human rights issue, Dr Carrie Foote told the Conference on Retroviruses and Opportunistic Infections (CROI 2019) in Seattle last week. “All people

Published
12 March 2019
By
Krishen Samuel
Achieving the 90-90-90 target
Largest ever HIV prevention study delivers sobering message

The recipe for ending HIV epidemics seems straightforward. Introduce widespread testing. Immediately put those who test positive on antiretroviral (ARV) drugs, which suppress the virus to undetectable levels so those people won’t infect others. The number of new infections will drop, and the epidemic will peter out. But massive, costly studies done in the past few years have failed to show this strategy can reliably curb the spread of the virus, to the frustration of researchers.

Published
12 March 2019
From
Science
Achieving the 90-90-90 target
Multiple benefits to scaling up universal test and treat in Africa

As well as the important findings of PopART, the largest HIV prevention trial ever conducted, this week’s Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle heard about

Published
08 March 2019
By
Roger Pebody
Undetectable viral load and treatment as prevention
The length of time Americans with HIV remain infectious is falling, but slowly

In 2016, more than half of people with HIV in the United States took more than three years to be diagnosed, and more than five months after

Published
07 March 2019
By
Roger Pebody
Achieving the 90-90-90 target
HIV infections lowered by 30% in universal testing and treatment study

Communities in southern Africa which received a door-to-door HIV testing intervention and support for linkage to care had substantially lower HIV incidence, the Conference on Retroviruses and

Published
06 March 2019
By
Roger Pebody
Undetectable viral load and treatment as prevention
HIV prevention study finds universal 'test and treat' approach can reduce new infections

New HIV infections declined by 30 percent in southern African communities where health workers conducted house-to-house voluntary HIV testing, referred people who tested positive to begin HIV treatment according to local guidelines, and offered other proven HIV prevention measures to those who tested negative. Local guidelines evolved during the study from offering HIV treatment based on immune health to offering immediate treatment for all.

Published
05 March 2019
From
NIH/National Institute of Allergy and Infectious Diseases
Undetectable viral load and treatment as prevention
'Test and Treat' reduces new HIV infections by a third in African communities

New HIV infections in southern Africa could be reduced substantially by offering entire communities voluntary HIV testing, and immediately referring those who test positive for HIV treatment in line with local guidelines, according to new research presented at the Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle, USA today.

Published
05 March 2019
From
Imperial College London
Treatment interruptions
HIV-positive participant in vaccine study passes virus to sexual partner during treatment interruption

An HIV-positive man transmitted HIV to his sexual partner after interrupting antiretroviral therapy as part of a research study into a therapeutic vaccine, French scientists reported in

Published
01 March 2019
By
Roger Pebody
← Prev12345...78Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.